Highley M - Search Results

1

Melphalan availability in hypoxia-inducible factor-1alpha+/+ and factor-1alpha-/- tumors is independent of tumor vessel density and correlates with melphalan erythrocyte transport.

Wildiers H, Guetens G, de Boeck G, Landuyt W, Verbeken E, Highley M, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Among authors: highley m. Int J Cancer. 2002 Jun 1;99(4):514-9. doi: 10.1002/ijc.10391. Int J Cancer. 2002. PMID: 11992540

2

In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.

Dumez H, Guetens G, De Boeck G, Highley MS, de Bruijn EA, van Oosterom AT, Maes RA. Dumez H, et al. Anticancer Drugs. 2005 Sep;16(8):893-5. doi: 10.1097/01.cad.0000175584.86198.ac. Anticancer Drugs. 2005. PMID: 16096439

3

Pharmacology of anticancer drugs in the elderly population.

Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Clin Pharmacokinet. 2003;42(14):1213-42. doi: 10.2165/00003088-200342140-00003. Clin Pharmacokinet. 2003. PMID: 14606930 Review.

4

The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment.

Dumez H, Guetens G, De Boeck G, Highley MS, Maes RA, van Oosterom AT, de Bruijn EA. Dumez H, et al. Clin Chem Lab Med. 2004;42(11):1219-27. doi: 10.1515/CCLM.2004.244. Clin Chem Lab Med. 2004. PMID: 15576286 Review.

5

Vascular endothelial growth factor and angiogenesis.

Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Hoeben A, et al. Pharmacol Rev. 2004 Dec;56(4):549-80. doi: 10.1124/pr.56.4.3. Pharmacol Rev. 2004. PMID: 15602010 Review.

6

In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender.

Dumez H, Guetens G, De Boeck G, Highley MS, de Bruijn EA, van Oosterom AT, Maes RA. Dumez H, et al. Anticancer Drugs. 2005 Sep;16(8):885-91. doi: 10.1097/01.cad.0000175585.24317.ca. Anticancer Drugs. 2005. PMID: 16096438

7

Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.

Guetens G, De Boeck G, Highley M, Dumez H, Van Oosterom AT, de Bruijn EA. Guetens G, et al. Among authors: highley m. J Chromatogr A. 2003 Dec 5;1020(1):27-34. doi: 10.1016/s0021-9673(03)00775-1. J Chromatogr A. 2003. PMID: 14661754

8

Everolimus alters imatinib blood partition in favour of the erythrocyte.

Prenen H, Guetens G, De Boeck G, Highley M, van Oosterom AT, de Bruijn EA. Prenen H, et al. Among authors: highley m. J Pharm Pharmacol. 2006 Aug;58(8):1063-6. doi: 10.1211/jpp.58.8.0006. J Pharm Pharmacol. 2006. PMID: 16872552

9

Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcome.

Dumez H, Highley M, Guetens G, De Boeck G, Hanauske A, van Oosterom AT, Maes RA, de Bruijn EA, Harper P. Dumez H, et al. Among authors: highley m. Semin Oncol. 2001 Apr;28(2 Suppl 8):24-8. doi: 10.1016/s0093-7754(01)90209-x. Semin Oncol. 2001. PMID: 11395849

10

The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors.

Dumez H, Louwerens M, Pawinsky A, Planting AS, de Jonge MJ, Van Oosterom AT, Highley M, Guetens G, Mantel M, de Boeck G, de Bruijn E, Verweij J. Dumez H, et al. Among authors: highley m. Anticancer Drugs. 2002 Jul;13(6):583-93. doi: 10.1097/00001813-200207000-00004. Anticancer Drugs. 2002. PMID: 12172503 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters